Keyword: series C

Poseida has put the kibosh on its IPO plans for now, settling instead for a $142 million series C round backed largely by Novartis.

Sight Diagnostics, maker of point-of-care blood diagnostic hardware, raised $27.8 million to continue its expansion and fund U.S. regulatory efforts.

Magnolia Medical Technologies raised $20 million in VC funding to scale up production of its Steripath device for reducing blood draw contamination.

Telehealth equipment maker Tyto Care raised an extra $9 million through its series C round, bringing its total up to $33.5 million.

Zymergen has raised over $400 million in a series C funding round, which it says will help double the capacity of its synthetic biology platform.

98point6, which makes primary care doctors available over cellphone messages, raised $50 million in a financing round led by Goldman Sachs.

MeMed raised $70 million for its immune system diagnostic for distinguishing between bacterial and viral infections, to reduce antibiotic misuse.

XACT Robotics raised $5 million alongside a CE mark for its integrated robotic system for image-guided, needle-puncture procedures, such as biopsies.

Rakuten Aspyrian raised $150 million to fund a phase 3 trial of its photoimmunotherapy platform in head and neck cancer.

Profusa raised more than $45 million in a series C round for its tissue-integrated biosensors.